Current Proteomics
Scope & Guideline
Fostering Collaboration in Proteomics Excellence
Introduction
Aims and Scopes
- Proteomic Analysis and Characterization:
The journal emphasizes studies that utilize proteomic techniques to analyze protein expression, modifications, and interactions. This includes quantitative proteomics, mass spectrometry, and protein profiling in various biological contexts. - Computational Proteomics and Bioinformatics:
A significant focus is placed on computational approaches to proteomics, including in silico studies, machine learning applications, and bioinformatics tools that assist in the interpretation of proteomic data and the prediction of protein functions. - Drug Discovery and Therapeutic Applications:
The journal features research that explores the role of proteomics in drug discovery, including the identification of potential biomarkers and therapeutic targets, as well as the evaluation of drug efficacy and mechanisms of action. - Clinical Applications and Disease Mechanisms:
Current Proteomics highlights studies that connect proteomic findings to clinical implications, disease mechanisms, and potential therapeutic strategies, thereby bridging the gap between basic research and clinical practice. - Innovative Methodologies in Proteomics:
The journal encourages submissions that report on novel proteomic techniques, including advancements in mass spectrometry, label-free quantification, and the integration of proteomics with other omics technologies.
Trending and Emerging
- Integration of Omics Technologies:
There is a growing trend towards integrating proteomics with genomics, metabolomics, and transcriptomics. This holistic approach allows for a more comprehensive understanding of biological systems and disease states. - Proteomics in Cancer Research:
The journal shows an increasing focus on the application of proteomics in cancer research, particularly in identifying biomarkers for diagnosis, prognosis, and treatment response, as well as understanding tumor biology. - Immunoinformatics and Vaccine Development:
Emerging studies are focusing on the use of proteomics in immunoinformatics for vaccine development. This includes the design of multi-epitope vaccines and the identification of immunogenic proteins from pathogens. - Personalized Medicine and Precision Proteomics:
There is a noticeable shift towards personalized medicine, with proteomics being leveraged to tailor treatments based on individual protein expression profiles and responses to therapies. - Computational Advancements and Machine Learning:
The application of machine learning and artificial intelligence in analyzing proteomic data is on the rise, offering new tools for data interpretation and predictive modeling within proteomics.
Declining or Waning
- Traditional Proteomic Approaches:
There seems to be a waning interest in traditional proteomic methodologies, such as two-dimensional gel electrophoresis, as researchers increasingly favor more advanced techniques like mass spectrometry-based approaches that offer higher resolution and sensitivity. - Basic Studies without Clinical Relevance:
Research focusing solely on basic proteomic studies without clear clinical applications or implications is becoming less common. The journal appears to prioritize studies that connect proteomic data to disease mechanisms or therapeutic implications. - Limited Scope of Plant Proteomics:
Although plant proteomics has been a significant area of research, recent publications suggest a decline in studies focused exclusively on plant proteins, possibly due to a broader focus on human health and disease-related proteomics.
Similar Journals
JOURNAL OF PROTEOME RESEARCH
Illuminating the Path of Biochemical DiscoveryJOURNAL OF PROTEOME RESEARCH is a premier publication in the field of proteomics, disseminating cutting-edge research and methodologies that drive advancements in biochemistry and molecular biology. Published by the American Chemical Society, this esteemed journal boasts a robust impact, as evidenced by its Q1 rankings in both Biochemistry and miscellaneous Chemistry categories for 2023. With a reputation bolstered by a solid Scopus ranking—#64 out of 408 in General Chemistry and #80 out of 438 in Biochemistry—the journal serves as an essential resource for researchers, professionals, and students aiming to deepen their understanding of protein functions and interactions in biological systems. Although it does not operate under an open-access model, the JOURNAL OF PROTEOME RESEARCH remains a critical platform for scholarly discourse, committed to publishing high-quality, peer-reviewed articles through 2024 and beyond. Scholars are encouraged to engage with the pioneering studies and reviews that shape the future of proteomics.
Bioinformatics and Biology Insights
Empowering researchers with open-access bioinformatics knowledge.Bioinformatics and Biology Insights is a premier open-access journal dedicated to advancing the frontiers of bioinformatics and biology. Published by SAGE Publications Ltd, this journal is a leading platform for disseminating high-quality research that integrates computational methods with biological insights. Since its inception in 2007, the journal has garnered significant recognition, reflecting its commitment to excellence, as evidenced by its impressive impact factor and a strong presence across multiple quartiles in applied mathematics, biochemistry, and computational sciences. With a rank of Q1 in both Applied Mathematics and Computational Mathematics and various other notable rankings in related fields, it serves as an essential resource for researchers, professionals, and students seeking cutting-edge knowledge and innovations. The journal's open-access model ensures that findings are readily available, fostering collaboration and advancement in this dynamic field. Through its comprehensive scope and rigorous peer-review process, Bioinformatics and Biology Insights continues to play a pivotal role in shaping the future of biological research and computational methodologies.
Proteomics Clinical Applications
Advancing Clinical Insights Through ProteomicsProteomics Clinical Applications, published by Wiley-VCH Verlag GmbH, is a pivotal journal in the realm of Clinical Biochemistry, with an impressive track record since its inception in 2007, continuing its impactful contributions to 2024. With an ISSN of 1862-8346 and an E-ISSN of 1862-8354, this prestigious journal currently holds a commendable Q2 ranking in Clinical Biochemistry, situated at the 54th percentile among its peers within Scopus rankings. Dedicated to the advancement of proteomics and its applications in clinical settings, Proteomics Clinical Applications serves as a bastion for innovative research, fostering knowledge exchange among scientists, healthcare professionals, and students alike. Through its focus on novel methodologies and translational research, the journal aims to bridge the gap between laboratory findings and clinical practice, significantly impacting patient care and outcomes. Although not open access, its content is accessible through various academic databases, ensuring that vital research reaches its intended audience.
PROTEIN AND PEPTIDE LETTERS
Connecting researchers with the latest in molecular mechanisms.PROTEIN AND PEPTIDE LETTERS is a prominent peer-reviewed journal published by Bentham Science Publishers Ltd, specializing in the dynamic fields of biochemistry and structural biology. With an ISSN of 0929-8665 and a corresponding E-ISSN of 1875-5305, the journal has been a pivotal platform for researchers since its inception in 1994. Spanning various aspects of protein and peptide research, it aims to disseminate groundbreaking findings that enhance our understanding of molecular mechanisms and therapeutic applications. Although categorized in the Q3 quartile for biochemistry and medicine, and Q4 in structural biology within the 2023 metrics, it remains a valuable resource in the academic arena, offering insight into the latest research and advancements. As the journal converges towards its 2024 milestone, it continues to reflect the evolving landscape of molecular research. While it currently does not offer open access, the accessibility to its impactful content is essential for students, professionals, and researchers invested in these critical scientific disciplines.
MOLECULAR & CELLULAR PROTEOMICS
Transforming proteomics with high-impact research.MOLECULAR & CELLULAR PROTEOMICS, published by Elsevier, stands as a premier journal in the fields of Biochemistry, Analytical Chemistry, and Molecular Biology, with a distinguished Q1 ranking reflecting its high impact and contribution to the scientific community. Established in 2002, this journal has consistently provided a platform for the latest research in protein science, merging molecular biology with advanced analytical techniques. With impressive Scopus rankings—41st in Biochemistry and 16th in Analytical Chemistry—it caters to an audience of researchers, professionals, and students eager to explore cutting-edge developments in proteomics. Although currently not designated as open access, the journal aims to foster knowledge dissemination through accessible research content. As it continues to evolve until 2024, MOLECULAR & CELLULAR PROTEOMICS is essential for anyone passionately engaged in the ever-expanding field of proteomics.
CURRENT PROTEIN & PEPTIDE SCIENCE
Navigating the Evolving Landscape of Protein and Peptide ScienceCURRENT PROTEIN & PEPTIDE SCIENCE, published by Bentham Science Publishers, is a pivotal journal dedicated to the dynamic and rapidly evolving fields of protein and peptide research. With an ISSN of 1389-2037 and an E-ISSN of 1875-5550, this esteemed journal serves as a platform for disseminating cutting-edge findings from various disciplines, including biochemistry, cell biology, and molecular biology. Recognized for its influence with a 2023 Scopus ranking placing it within the top quartiles of its categories—Q3 in Biochemistry, Q4 in Cell Biology, and Q2 in Medicine—the journal not only enhances the visibility of critical research but also supports the academic community in advancing our understanding of the molecular foundations of life. Established in 2000 and running through 2024, CURRENT PROTEIN & PEPTIDE SCIENCE is positioned to cater to the interests of researchers, professionals, and students alike, providing them with open access to vital knowledge that fuels innovation and scientific inquiry in the United Arab Emirates and beyond.
JOURNAL OF BIOLOGICAL CHEMISTRY
Unveiling Molecular Mysteries, One Study at a TimeJOURNAL OF BIOLOGICAL CHEMISTRY, published by Elsevier, is a premier interdisciplinary journal dedicated to advancing our understanding of biochemistry, cell biology, and molecular biology. With a prestigious history dating back to 1945 and an impressive convergence of research expected to continue through 2024, this journal holds a Q1 ranking in all three of its core categories, signaling its critical influence in the respective fields, supported by a robust Scopus ranking that places it among the top echelons of internationally recognized research. Although currently not available as Open Access, the journal is essential for researchers and professionals looking to stay abreast of the latest breakthroughs and innovations in biochemical research. With a deep commitment to scientific rigor and a focus on diverse topics ranging from cellular processes to molecular mechanisms, the Journal of Biological Chemistry serves as a vital resource for the academic community, shaping the future of biological sciences.
MedComm is a distinguished Open Access journal published by Wiley, located in the United States. Since its inception in 2020, it has rapidly established itself as a leading platform for cutting-edge research in the fields of Biochemistry, Cell Biology, Drug Discovery, Genetics, Immunology and Allergy, and Oncology, achieving a prestigious Q1 category ranking across multiple disciplines in 2023. MedComm is committed to providing a rigorous and transparent peer-review process, ensuring the publication of high-quality articles that advance the frontiers of medical science. With its remarkable Scopus ranking, the journal serves as an invaluable resource for researchers, professionals, and students looking to stay abreast of important developments in the life sciences. The open access model facilitates widespread dissemination of scholarly work, fostering collaboration and innovation within the global scientific community. Researchers interested in submitting their work or exploring the latest findings are encouraged to engage with this pivotal journal during the converged years from 2020 to 2024.
Cell Reports Methods
Transforming Research with Innovative MethodologiesCell Reports Methods is a cutting-edge journal published by CELL PRESS, focusing on innovative methodologies in the vast fields of biochemistry, genetics, biotechnology, and radiological sciences. Launched in 2021, it has rapidly ascended to attain a Q1 ranking across multiple disciplines in the latest 2023 metrics, reflecting its influential contribution to the scientific community. With an emphasis on practical and rigorous experimental approaches, this journal serves as a vital resource for researchers looking to advance their methodologies and collaborate on significant findings in their respective specialties. Despite not being an open-access publication, Cell Reports Methods ensures broad accessibility through institutional subscriptions, allowing researchers from various backgrounds to engage with high-quality scholarly work. The journal presents a unique platform for sharing insights from interdisciplinary methods that foster innovation and discovery, ultimately shaping the future of scientific research.
PROTEOMICS
Pioneering discoveries in protein function and interaction.PROTEOMICS is a leading journal focused on the rapidly evolving field of proteomics, published by WILEY in Germany. With a solid reputation established since its inception in 2001, it has continually contributed to the understanding of protein functions and interactions within biological systems. As part of its commitment to academic excellence, PROTEOMICS is ranked in the second quartile for both Biochemistry and Molecular Biology categories (2023), reflecting its significant influence in advancing research in these areas. Although it does not currently provide open access options, it remains a vital resource for researchers, professionals, and students keen to explore innovative methodologies and findings in proteomic research. By publishing groundbreaking studies that bridge theoretical knowledge with practical applications, PROTEOMICS plays a crucial role in enhancing our understanding of molecular processes and driving forward advancements in the life sciences.